Sign in
CompletedNo phase

PMCF Study on EDOF (Isopure) vs Monofocal (Micropure) IOL

Key facts

Who runs it
Beaver-Visitec International, Inc.
Where
Austria, Czechia, Germany, Ireland, Philippines, and Spain12 sites in 6 countriesChoose a country to see its sites
Trial code
Status
Completed
People taking part
250 people enrolled
Started
11 Feb 2020
Ended
18 Apr 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • IOL implantation experimental (Isopure 1.2.3.)
  • IOL implantation active comparator (Micropure 1.2.3.)
Record updated
21 November 2025

Who can take part

Age
45 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 22 criteriaShow less

Who can take part

  • Cataractous eyes with no comorbidity
  • Calculated IOL power is within the range of the study IOLs
  • Male or female adults ages 45 years or older on the day of screening who have cataract(s) in one or both eyes
  • Regular corneal astigmatism ≤1.0 D (measured by an automatic keratometer)
  • Clear intraocular media other than cataract
  • Availability, willingness and sufficient cognitive awareness to comply with examination procedures
  • Signed informed consent

Who cannot take part

  • Previous intraocular or corneal surgery
  • Expected complicated surgery
  • Difficulty for cooperation (distance from their home, general health conditions)
  • Subjects with diagnosed degenerative visual disorders (e.g. macular degeneration or other retinal or optic disorders) that are predicted to cause future acuity losses to a level of 20/30 or worse
  • Ocular hypertension or glaucoma
  • Pupil abnormalities (non-reactive, tonic pupils, abnormally shaped pupils or pupils that do not dilate under mesopic / scotopic conditions)
  • Age of patient < 45 years
  • Regular corneal astigmatism >1.0 dioptres (measured by an automatic keratometer)
  • Irregular astigmatism
  • Subjects with AMD suspicious eyes as determined by OCT examination
  • Subjects who may be expected to require retinal laser treatment during the course of the study or at a greater risk of developing cystoid macular edema
  • Traumatic cataract
  • History or presence of macular edema
  • Instability of keratometry or biometry measurements
  • Significant dry eye

Where is this trial?

It has sites in 6 countries. Choose a country to see its sites.

About the trial

What the trial wants to find out

Multicenter, prospective, randomised, controlled, single-blind post-market clinical follow-up (PMCF) study to compare the clinical outcomes of an enhanced depth of focus (EDOF) IOL with the outcomes obtained with a monofocal lens. Implantation of the IOLs is bilaterally.

The 2 groups in the trial

  • IOL implantation experimentalTreatment being tested

    Experimental arm: Enhanced depth of focus (EDOF) intraocular lens.

    Treatment: IOL implantation experimental (Isopure 1.2.3.)

  • IOL implantation active comparatorExisting treatment, for comparison

    Comparator arm: Monofocal intraocular lens.

    Treatment: IOL implantation active comparator (Micropure 1.2.3.)

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Multicentric Post-Market Clinical Follow-up (PMCF) Investigation to Determine Safety and Efficacy of a Hydrophobic EDOF Intraocular Lens (IOL) in Comparison to a Monofocal IOL
Record updated
21 November 2025